menu
    • menu

    Company profile for Visus Therapeutics

    NEW Drugs in Dev: 2
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Visus Therapeutics has assembled a team of renowned leaders with vast eye care experience, united by the common goal of advancing drug discovery to benefit the patients we serve. Veterans in the successful development and commercialization of eye care pharmaceuticals, we are leveraging our collective knowledge and experience to bring forward advancements in ophthalmic therapeutics with a lead program in presbyopia.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Visus TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    500 Yale Avenue N. Seattle, WA 98109
    Telephone
    Telephone
    (800) 281-4536
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.visustx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    34th NZW-Hamburg

    Not Confirmed

    envelop Contact Supplier

    34th NZW-Hamburg

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vis’ Yuvezzi Receives Approval in US
    Vis’ Yuvezzi Receives Approval in US

    28 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220142

    FDA
    28 Jan 2026
    Share Share
    2 eye disease biotechs merge, set sights on FDA approval
    2 eye disease biotechs merge, set sights on FDA approval

    12 Dec 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/tenpoint-visus-merge-efforts-push-presbyopia-correcting-eye-drop-over-fda-finish-line

    FIERCE BIOTECH
    12 Dec 2024
    Share Share
    Visus Therapeutics to Present at 2023 JMP Securities Life Science Conference
    Visus Therapeutics to Present at 2023 JMP Securities Life Science Conference

    12 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230512005175/en

    BUSINESSWIRE
    12 May 2023
    Share Share
    Visus Announces Positive Topline Clinical Data from Ph3 Pivotal BRIO-I Trial
    Visus Announces Positive Topline Clinical Data from Ph3 Pivotal BRIO-I Trial

    20 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230419006081/en

    BUSINESSWIRE
    20 Apr 2023
    Share Share
    Visus Therapeutics Announces New Scientific Data to Be Presented During the 2023
    Visus Therapeutics Announces New Scientific Data to Be Presented During the 2023

    19 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230419005378/en

    BUSINESSWIRE
    19 Apr 2023
    Share Share
    Visus Appoints Industry Expert Jehan Tamboowalla to Senior VP
    Visus Appoints Industry Expert Jehan Tamboowalla to Senior VP

    12 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230412005322/en

    BUSINESSWIRE
    12 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Contact Visus Therapeutics and get a quotation

    Visus Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Carbachol bulk with DMF offered by Visus Therapeutics

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search